The YHD inhibition of 4T1 breast tumor growth may be related to the negative regulation of the JAK/STAT3 pathway by repressing the expression of IL-6 and TGF-β (Mao, Feng & Gong, 2018). Here, STAT3 is linked to breast neoplasm.